These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 37964355)

  • 1. CRISPR/Cas9 system: recent applications in immuno-oncology and cancer immunotherapy.
    Chen C; Wang Z; Qin Y
    Exp Hematol Oncol; 2023 Nov; 12(1):95. PubMed ID: 37964355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current applications and future perspective of CRISPR/Cas9 gene editing in cancer.
    Wang SW; Gao C; Zheng YM; Yi L; Lu JC; Huang XY; Cai JB; Zhang PF; Cui YH; Ke AW
    Mol Cancer; 2022 Feb; 21(1):57. PubMed ID: 35189910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances and applications of CRISPR-Cas9 in cancer immunotherapy.
    Liu Z; Shi M; Ren Y; Xu H; Weng S; Ning W; Ge X; Liu L; Guo C; Duo M; Li L; Li J; Han X
    Mol Cancer; 2023 Feb; 22(1):35. PubMed ID: 36797756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innovative Strategies of Reprogramming Immune System Cells by Targeting CRISPR/Cas9-Based Genome-Editing Tools: A New Era of Cancer Management.
    Allemailem KS; Alsahli MA; Almatroudi A; Alrumaihi F; Al Abdulmonem W; Moawad AA; Alwanian WM; Almansour NM; Rahmani AH; Khan AA
    Int J Nanomedicine; 2023; 18():5531-5559. PubMed ID: 37795042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR/Cas9 Gene-Editing in Cancer Immunotherapy: Promoting the Present Revolution in Cancer Therapy and Exploring More.
    Ou X; Ma Q; Yin W; Ma X; He Z
    Front Cell Dev Biol; 2021; 9():674467. PubMed ID: 34095145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The application of CRISPR-Cas9 genome editing tool in cancer immunotherapy.
    Wu HY; Cao CY
    Brief Funct Genomics; 2019 Mar; 18(2):129-132. PubMed ID: 29579146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applications of CRISPR-Cas9 for advancing precision medicine in oncology: from target discovery to disease modeling.
    Ravichandran M; Maddalo D
    Front Genet; 2023; 14():1273994. PubMed ID: 37908590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The applications of CRISPR screen in functional genomics.
    Qi X; Zhang J; Zhao Y; Chen T; Xiang Y; Hui J; Cai D; Liu Y; Xia L; Yu T; Li G
    Brief Funct Genomics; 2017 Jan; 16(1):34-37. PubMed ID: 27329784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Principles, Applications, and Biosafety of Plant Genome Editing Using CRISPR-Cas9.
    El-Mounadi K; Morales-Floriano ML; Garcia-Ruiz H
    Front Plant Sci; 2020; 11():56. PubMed ID: 32117392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR technology for immuno-oncology applications.
    Wang J; Balan V; Marincola F
    Methods Enzymol; 2020; 635():251-266. PubMed ID: 32122549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-editing approaches and applications: a brief review on CRISPR technology and its role in cancer.
    Siva N; Gupta S; Gupta A; Shukla JN; Malik B; Shukla N
    3 Biotech; 2021 Mar; 11(3):146. PubMed ID: 33732568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR-Cas9, A Promising Therapeutic Tool for Cancer Therapy: A Review.
    Akram F; Ikram Ul Haq ; Ahmed Z; Khan H; Ali MS
    Protein Pept Lett; 2020; 27(10):931-944. PubMed ID: 32264803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of CRISPR/Cas9-Edited PD-1/PD-L1 on Tumor Immunity and Immunotherapy.
    Xu Y; Chen C; Guo Y; Hu S; Sun Z
    Front Immunol; 2022; 13():848327. PubMed ID: 35300341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applications and advances of CRISPR-Cas9 in cancer immunotherapy.
    Xia AL; He QF; Wang JC; Zhu J; Sha YQ; Sun B; Lu XJ
    J Med Genet; 2019 Jan; 56(1):4-9. PubMed ID: 29970486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advancing chimeric antigen receptor T cell therapy with CRISPR/Cas9.
    Ren J; Zhao Y
    Protein Cell; 2017 Sep; 8(9):634-643. PubMed ID: 28434148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in therapeutic application of CRISPR-Cas9.
    Sun J; Wang J; Zheng D; Hu X
    Brief Funct Genomics; 2020 May; 19(3):164-174. PubMed ID: 31769791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR-Cas9 for medical genetic screens: applications and future perspectives.
    Xue HY; Ji LJ; Gao AM; Liu P; He JD; Lu XJ
    J Med Genet; 2016 Feb; 53(2):91-7. PubMed ID: 26673779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging CRISPR/Cas9 applications for T-cell gene editing.
    Preece R; Georgiadis C
    Emerg Top Life Sci; 2019 May; 3(3):261-275. PubMed ID: 33523139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR/Cas9 Delivery System Engineering for Genome Editing in Therapeutic Applications.
    Cheng H; Zhang F; Ding Y
    Pharmaceutics; 2021 Oct; 13(10):. PubMed ID: 34683943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.